Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nat Methods ; 17(4): 380-389, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32152500

RESUMEN

Understanding how chromatin is regulated is essential to fully grasp genome biology, and establishing the locus-specific protein composition is a major step toward this goal. Here we explain why the isolation and analysis of a specific chromatin segment are technically challenging, independently of the method. We then describe the published strategies and discuss their advantages and limitations. We conclude by discussing why significant technology developments are required to unambiguously describe the composition of small single loci.


Asunto(s)
Cromatina , Mapeo Cromosómico , Cromosomas/genética , Sitios Genéticos , Genoma/fisiología , Inmunoprecipitación de Cromatina , Humanos
2.
Sci Adv ; 5(5): eaav3673, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31086817

RESUMEN

Alternative lengthening of telomeres, or ALT, is a recombination-based process that maintains telomeres to render some cancer cells immortal. The prevailing view is that ALT is inhibited by heterochromatin because heterochromatin prevents recombination. To test this model, we used telomere-specific quantitative proteomics on cells with heterochromatin deficiencies. In contrast to expectations, we found that ALT does not result from a lack of heterochromatin; rather, ALT is a consequence of heterochromatin formation at telomeres, which is seeded by the histone methyltransferase SETDB1. Heterochromatin stimulates transcriptional elongation at telomeres together with the recruitment of recombination factors, while disrupting heterochromatin had the opposite effect. Consistently, loss of SETDB1, disrupts telomeric heterochromatin and abrogates ALT. Thus, inhibiting telomeric heterochromatin formation in ALT cells might offer a new therapeutic approach to cancer treatment.


Asunto(s)
Heterocromatina/metabolismo , N-Metiltransferasa de Histona-Lisina/metabolismo , Acortamiento del Telómero , Telómero/metabolismo , Animales , Línea Celular Tumoral , Chaperonas de Histonas/metabolismo , N-Metiltransferasa de Histona-Lisina/antagonistas & inhibidores , N-Metiltransferasa de Histona-Lisina/deficiencia , N-Metiltransferasa de Histona-Lisina/genética , Humanos , Metiltransferasas/deficiencia , Metiltransferasas/genética , Ratones , Ratones Endogámicos C57BL , Células Madre Embrionarias de Ratones/citología , Células Madre Embrionarias de Ratones/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Proteínas Represoras/deficiencia , Proteínas Represoras/genética , Proteína 2 de Unión a Repeticiones Teloméricas/metabolismo , Proteína Nuclear Ligada al Cromosoma X/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA